Yüklüyor......

Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial

In this randomized, double-blind, controlled, parallel group study (ZENITH), 434 essential hypertensives with additional cardiovascular risk factors, uncontrolled by a previous monotherapy, were treated for 18 weeks with zofenopril 30 or 60 mg plus hydrochlorothiazide (HCTZ) 12.5 mg or irbesartan 15...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Hypertens
Asıl Yazarlar: Malacco, Ettore, Omboni, Stefano, Parati, Gianfranco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540998/
https://ncbi.nlm.nih.gov/pubmed/26347187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/139465
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!